Dr.agarwals Eye Hospital Ltd.-$ vs HCA Healthcare: Fair Value & Quality
Both stocks run through our valuation models. Here is how Dr.agarwals Eye Hospital Ltd.-$ (DRAGARWQ) and HCA Healthcare (HCA) compare, as of Aug 20, 2026.
As of Aug 20, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dr.agarwals Eye Hospital Ltd.-$ trades at ₹5,316 versus a fair value of ₹3,191 (-40%), while HCA Healthcare trades at $407 versus $548 (+35%).
Dr.agarwals Eye Hospital Ltd.-$
DRAGARWQ.BSE · INR · Healthcare
-40%
upside to fair value
overvalued
Price₹5,316
Fair Value₹3,191
Quality54/100
HCA Healthcare
HCA · USD · Health Care
+35%
upside to fair value
undervalued
Price$407
Fair Value$548
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Dr.agarwals Eye Hospital Ltd.-$HCA Healthcare
Valuation
36.2×P/E (TTM)14.1×
5.17×P/S (TTM)1.06×
7.02×P/B—
17.2×EV/EBITDA7.8×
—PEG1.18×
0.1%Dividend yield0.7%
₹7.00Dividend per share$2.94
Profitability
15%Net margin9%
18%Operating margin15%
25%Return on equity136%
9%Return on assets12%
Growth
20%Revenue growth (YoY)4%
20.8%Avg. growth/yr (3Y)7.9%
27.5%Avg. growth/yr (5Y)8.0%
Balance & size
0.19×Debt / equity—
$253MMarket cap$81B
expensiveGrowth qualityhealthy
HCA Healthcare leads: 5 to 6 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Dr.agarwals Eye Hospital Ltd.-$of which business quality 55 · market factors 61HCA Healthcareof which business quality 66 · market factors 40
ProfitabilityMargins and returns on capital today
65
76
Quality GrowthAre margins and returns improving?
58
61
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
0
75
Low VolatilityCalm price path (market factor)
83
59
MomentumPrice trend over the last 3–12 months (market factor)
52
29
52W MomentumDistance to the 52-week high (market factor)
52
37
Net IssuanceBuybacks instead of dilution
63
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Dr.agarwals Eye Hospital Ltd.-$
DCF Models₹3,845
Earnings-Based₹2,926
Multiples₹2,859
Asset-Based₹480
Growth DCF₹3,182
Economic Profit₹2,186
Growth Earnings₹4,073
23 of 24 models see the stock below the current price.
HCA Healthcare
DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506
6 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Dr.agarwals Eye Hospital Ltd.-$
Bear ₹1,509Fair Value ₹3,191Bull ₹3,989
₹5,316 = current price (white tick)
HCA Healthcare
Bear $260Fair Value $548Bull $841
$407 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Dr.agarwals Eye Hospital Ltd.-$ · Healthcare
Quality score54 · above median
Fair value upside-40% · below median
HCA Healthcare · Health Care
Quality score70 · Top 25%
Fair value upside+35% · Top 25%
Bottom line
As of Aug 20, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dr.agarwals Eye Hospital Ltd.-$ trades at ₹5,316 versus a fair value of ₹3,191 (-40%), while HCA Healthcare trades at $407 versus $548 (+35%).
HCA Healthcare has the higher quality score (70/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
